Skip to main content
SpringerLink
Log in

Adoption of a national antimicrobial guide (SWAB-ID) in the Netherlands

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. World Health Organization (2014) Global strategy for containment of antimicrobial resistance. Geneva, Switzerland: WHO

  2. Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M (2014) A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis 14:13. doi:10.1186/1471-2334-14-13

    Article  PubMed  PubMed Central  Google Scholar 

  3. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44(2):159–177. doi:10.1086/510393

    Article  PubMed  Google Scholar 

  4. Eccles M, Clapp Z, Grimshaw J, Adams PC, Higgins B, Purves I, Russell I (1996) Developing valid guidelines: methodological and procedural issues from the North of England Evidence Based Guideline Development Project. Qual Health Care 5(1):44–50

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  5. van Vonderen MG, Gyssens IC, Hartwig NG, Kullberg BJ, Leverstein-van Hall MA, Natsch S, Prins JM (2006) Optimalisation of the antibiotic policy in The Netherlands. XI. The national electronic antibiotic guide ‘SWAB-ID’ for use in hospitals. Ned Tijdschr Geneeskd 150(46):2560–2564

    PubMed  Google Scholar 

  6. Arnold FW, LaJoie AS, Brock GN, Peyrani P, Rello J, Menendez R, Lopardo G, Torres A, Rossi P, Ramirez JA (2009) Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arch Intern Med 169(16):1515–1524. doi:10.1001/archinternmed.2009.265

    Article  PubMed  Google Scholar 

  7. Asadi L, Eurich DT, Gamble JM, Minhas-Sandhu JK, Marrie TJ, Majumdar SR (2013) Impact of guideline-concordant antibiotics and macrolide/beta-lactam combinations in 3203 patients hospitalized with pneumonia: prospective cohort study. Clin Microbiol Infect 19(3):257–264. doi:10.1111/j.1469-0691.2012.03783.x

    Article  PubMed  CAS  Google Scholar 

  8. Larson EL, Quiros D, Giblin T, Lin S (2007) Relationship of antimicrobial control policies and hospital and infection control characteristics to antimicrobial resistance rates. Am J Crit Care 16(2):110–120

    PubMed  PubMed Central  Google Scholar 

  9. Lee SS, Kim Y, Chung DR (2011) Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis. J Infect 62(2):159–164. doi:10.1016/j.jinf.2010.10.009

    Article  PubMed  Google Scholar 

  10. Menendez R, Torres A, Reyes S, Zalacain R, Capelastegui A, Aspa J, Borderias L, Martin-Villasclaras JJ, Bello S, Alfageme I, de Castro FR, Rello J, Molinos L, Ruiz-Manzano J (2012) Initial management of pneumonia and sepsis: factors associated with improved outcome. Eur Respir J 39(1):156–162. doi:10.1183/09031936.00188710

    Article  PubMed  CAS  Google Scholar 

  11. Spoorenberg V, Prins JM, Stobberingh EE, Hulscher ME, Geerlings SE (2013) Adequacy of an evidence-based treatment guideline for complicated urinary tract infections in the Netherlands and the effectiveness of guideline adherence. Eur J Clin Microbiol Infect Dis 32(12):1545–1556. doi:10.1007/s10096-013-1909-6

    Article  PubMed  CAS  Google Scholar 

  12. NethMap (2014) Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in The Netherlands in 2013

    Google Scholar 

  13. Al Mahdy H (2012) Quality assuring adult anti-microbial guidelines. Int J Health Care Qual Assur 25(3):226–231. doi:10.1108/09526861211210448

    Article  PubMed  Google Scholar 

  14. Milinovich GJ, Hu W (2013) Web based surveillance systems could improve disease detection and the response to emerging disease events. BMJ 347:f4276. doi:10.1136/bmj.f4276

    Article  PubMed  Google Scholar 

  15. Carneiro HA, Mylonakis E (2009) Google trends: a web-based tool for real-time surveillance of disease outbreaks. Clin Infect Dis 49(10):1557–1564. doi:10.1086/630200

    Article  PubMed  Google Scholar 

  16. Troppy S, Haney G, Cocoros N, Cranston K, DeMaria A Jr (2014) Infectious disease surveillance in the 21st century: an integrated web-based surveillance and case management system. Public Health Rep 129(2):132–138

    PubMed  PubMed Central  Google Scholar 

  17. Pagani L, Gyssens IC, Huttner B, Nathwani D, Harbarth S (2009) Navigating the Web in search of resources on antimicrobial stewardship in health care institutions. Clin Infect Dis 48(5):626–632. doi:10.1086/596762

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The Dutch Working Party on Antibiotic Policy (SWAB) is financially supported by the National Institute for Public Health and the Environment (RIVM).

Contribution of authors statement

Emelie C. Schuts had substantial contributions to the conception or design and the interpretation of data for the work, drafting the work, final approval of the version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Caroline M.A. van den Bosch had substantial contributions to the conception or design and the interpretation of data for the work, revising the work critically for important intellectual content, final approval of the version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Inge C. Gyssens had substantial contributions to the interpretation of data for the work, revising the work critically for important intellectual content, final approval of the version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Bart-Jan Kullberg had substantial contributions to the interpretation of data for the work, revising the work critically for important intellectual content, final approval of the version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Maurine A. Leverstein-van Hall had substantial contributions to the interpretation of data for the work, revising the work critically for important intellectual content, final approval of the version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Stephanie Natsch had substantial contributions to the interpretation of data for the work, revising the work critically for important intellectual content, final approval of the version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Fre Sebens had substantial contributions to the interpretation of data for the work, revising the work critically for important intellectual content, final approval of the version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Martha B. Adams had substantial contributions to the interpretation of data for the work, revising the work critically for important intellectual content, final approval of the version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Richard Drew had substantial contributions to the interpretation of data for the work, revising the work critically for important intellectual content, final approval of the version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Jan M. Prins had substantial contributions to the conception or design and the interpretation of data for the work, revising the work critically for important intellectual content, final approval of the version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Author information

Authors and Affiliations

  1. Center for Infection and Immunity Amsterdam (CINIMA), Division of Infectious Diseases, Department of Internal Medicine, Academic Medical Center, Room F4-217, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands

    Emelie C. Schuts, Caroline M. van den Bosch & Jan M. Prins

  2. Radboud Center for Infectious Diseases, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

    Inge C. Gyssens & Bart-Jan Kullberg

  3. Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands

    Inge C. Gyssens

  4. Hasselt University, Hasselt, Belgium

    Inge C. Gyssens

  5. Department of Medical Microbiology, Bronovo Hospital, Den Haag and Diaconessenhuis, Leiden, The Netherlands

    Maurine A. Leverstein-van Hall

  6. Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands

    Stephanie Natsch

  7. Department of Medical Microbiology and Infection Control, Deventer Ziekenhuis, Deventer, The Netherlands

    Fre Sebens

  8. Duke University Medical Center, Durham, NC, 27710, USA

    Martha B. Adams

  9. Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, 27710, USA

    Richard Drew

Authors
  1. Emelie C. Schuts
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caroline M. van den Bosch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Inge C. Gyssens
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bart-Jan Kullberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maurine A. Leverstein-van Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stephanie Natsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fre Sebens
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Martha B. Adams
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Richard Drew
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jan M. Prins
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Emelie C. Schuts or Jan M. Prins.

Ethics declarations

Competing interest

All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schuts, E.C., van den Bosch, C.M., Gyssens, I.C. et al. Adoption of a national antimicrobial guide (SWAB-ID) in the Netherlands. Eur J Clin Pharmacol 72, 249–252 (2016). https://doi.org/10.1007/s00228-015-1969-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-015-1969-x

Keywords

Search

Navigation